NCT00653614View on ClinicalTrials.gov

Cycle Control and Safety of E2-DRSP

PHASE2CompletedINTERVENTIONAL
Enrollment

635

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Contraceptive, Oral, Hormonal
Interventions
DRUG

E2/DRSP (BAY 86-4891) dose 1 (SH T04984E)

Single dose administration of E2 + DRSP as a tablet

DRUG

E2/DRSP (BAY 86-4891) dose 2 (80458739)

Single dose administration of E2 + DRSP as a tablet

DRUG

E2/DRSP (BAY 86-4891) dose 3 (80458755)

Single dose administration of E2 + DRSP as a tablet

DRUG

E2/DRSP (BAY 86-4891) dose 4 (80458720)

Single dose administration of E2 + DRSP as a tablet

DRUG

E2/DRSP (BAY 86-4891) dose 5 (80458712)

Single dose administration of E2 + DRSP as a tablet

DRUG

DRSP (ZK 30595) dose 1 (SH T04984F)

Single dose administration of DRSP as a tablet

DRUG

DRSP (ZK 30595) dose 2 (80458690)

Single dose administration of DRSP as a tablet

DRUG

Placebo

Placebo administration in each arm

Trial Locations (25)

10247

Berlin

12587

Berlin

13086

Berlin

13507

Berlin

21073

Hamburg

22159

Hamburg

36037

Fulda

38889

Blankenburg

39104

Magdeburg

39126

Magdeburg

39288

Burg

60322

Frankfurt am Main

63128

Dietzenbach

63165

Mühlheim am Main

65936

Frankfurt am Main

86381

Krumbach

90491

Nuremberg

01744

Dippoldiswalde

01099

Dresden

01169

Dresden

04207

Leipzig

04299

Leipzig

04808

Wurzen

06917

Jessen

07545

Gera

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00653614 - Cycle Control and Safety of E2-DRSP | Biotech Hunter | Biotech Hunter